$DOCS News

Barclays Maintains Equal-Weight on Doximity, Raises Price Target to $27

Doximity (DOCS) Stock Looks Cheap On Cash Flow Yet Fair On Earnings

Doximity (DOCS) Could Be 26% Below Fair Value On Strong Earnings Guidance

A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know

What Investors Should Know of This Doximity Officer's Latest Insider Transaction

Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors

Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.

Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?

The 5 Most Interesting Analyst Questions From Doximity’s Q2 Earnings Call

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity Doubled, Then Gave Most of It Back. Here’s Why the Market Doesn’t Trust the Rally

Truist Securities Maintains Hold on Doximity, Raises Price Target to $24

Wells Fargo Downgrades Doximity (DOCS)

DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures

Doximity Draws Its First Downgrade Days After Its Pop

Wells Fargo Downgrades Doximity to Underweight, Maintains Price Target to $18

Doximity (DOCS) Stock Fair Value Rises After Split Analyst Views On AI Growth

Doximity: I Called The Pop Over A Month Ago, But Now Is The Time To Wait (Rating Downgrade)

Doximity Q1 Earnings Call Highlights

Why Doximity Stock Is Up 80%